表紙:遺伝子パネルの世界市場
市場調査レポート
商品コード
1199155

遺伝子パネルの世界市場

Gene Panel

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 197 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
遺伝子パネルの世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 197 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の遺伝子パネルの市場規模は、2022年に21億米ドルとなり、2030年には88億米ドルに達し、2022年~2030年にかけてCAGRで19.6%の成長が予測されています。

当レポートでは、世界の遺伝子パネル市場について調査し、市場概要、市場動向と促進要因、市場分析等に関する情報を提供しています。

主要競合企業(全47社)

  • Agilent Technologies, Inc.
  • ArcherDX, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • GENEWIZ
  • Illumina, Inc.
  • Integrated DNA Technologies(IDT), Inc.
  • Personalis, Inc.
  • QIAGEN GmbH
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP12156

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Gene Panel Market to Reach $8.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Gene Panel estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$8.8 Billion by 2030, growing at aCAGR of 19.6% over the period 2022-2030. Test Kits, one of the segments analyzed in the report, is projected to record 18.2% CAGR and reach US$5.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Testing Services segment is readjusted to a revised 22.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $611 Million, While China is Forecast to Grow at 18.5% CAGR

The Gene Panel market in the U.S. is estimated at US$611 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 18.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.1% and 17% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.

Select Competitors (Total 47 Featured):

  • Agilent Technologies, Inc.
  • ArcherDX, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • GENEWIZ
  • Illumina, Inc.
  • Integrated DNA Technologies (IDT), Inc.
  • Personalis, Inc.
  • QIAGEN GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Gene Panel: A Prelude
    • Gene Panel - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Gene Panel Methods
    • Gene Panel Analysis and the Exome Analysis
    • Evaluation of Gene Panel
    • Cancer Gene Panels
    • Multi-Gene Panel Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Gene Panel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cancer Risk Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Cancer Risk Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Diagnosis of Congenital Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Diagnosis of Congenital Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Gene Panel Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • Active Players in United States
    • TABLE 22: USA Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • CANADA
    • Active Players in Canada
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • JAPAN
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • Active Players in Japan
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • CHINA
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • Active Players in China
    • TABLE 40: China Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • EUROPE
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Gene Panel by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • FRANCE
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • Active Players in France
    • TABLE 54: France Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • GERMANY
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • Active Players in Germany
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • ITALY
    • Active Players in Italy
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • UNITED KINGDOM
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • Active Players in United Kingdom
    • TABLE 72: UK Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • REST OF EUROPE
    • Active Players in Rest of Europe
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Gene Panel Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • Active Players in Asia-Pacific
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030
  • REST OF WORLD
    • Active Players in Rest of World
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of World 8-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World 8-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2023 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Gene Panel by End-Use - Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostic Laboratories, Pharma & Biotech Companies and Research & Academic Institutes for the Years 2023 & 2030

IV. COMPETITION